Home › Funds › CPP Investments › IMVT
CPP Investments position in IMVT
IMMUNOVANT INC · Health Care
Latest position (Q2 2026)22.50K sh
Reported value held$866.92K
Portfolio Weight0.00%
First reportedQ2 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 199.80K | $5.27M | New |
| Q3 2024 | 1.20K | $34.21K | Reduce |
| Q4 2024 | 95.20K | $2.36M | Add |
| Q1 2025 | 182.50K | $3.12M | Add |
| Q2 2025 | 414.80K | $6.64M | Add |
| Q3 2025 | 414.80K | $6.69M | Hold |
| Q4 2025 | 5.20K | $132.18K | Reduce |
| Q1 2026 | 23.20K | $576.29K | Add |
| Q2 2026 | 22.50K | $866.92K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IMVT
- Fidelity Management & Research (FMR) 16.19M sh · $623.66M · Q2 2026
- BlackRock Inc 7.18M sh · $276.68M · Q2 2026
- Farallon Capital Management 5.80M sh · $223.67M · Q2 2026
- Vanguard Group 7.78M sh · $197.75M · Q4 2025
- Morgan Stanley 4.53M sh · $174.73M · Q2 2026
- Geode Capital Management 2.23M sh · $86.12M · Q2 2026
- Goldman Sachs Group 1.75M sh · $67.47M · Q2 2026
- D. E. Shaw & Co 1.24M sh · $47.80M · Q2 2026
- Bank of America Corp 1.18M sh · $45.52M · Q2 2026
- Northern Trust Corp 794.00K sh · $30.59M · Q2 2026
- Renaissance Technologies 726.80K sh · $28.00M · Q2 2026
- Charles Schwab Investment Management 680.59K sh · $26.22M · Q2 2026